Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.55 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.55 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.53 |
| ▸ | HTR2A | P28223 | 2/20 | 0.53 |
| ▸ | HTR2B | P41595 | 2/20 | 0.53 |
| ▸ | HTR2C | P28335 | 2/20 | 0.53 |
| ▸ | LPL | P06858 | 2/20 | 0.51 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.51 |
| ▸ | MIF | P14174 | 1/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.50 |
| ▸ | IDO1 | P14902 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.50 |
| ▸ | DRD3 | P35462 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28260251 | 0.98 | TAAR1 (0.59) | TAAR1HDAC1HDAC8TRPV1HTR2A | |
| SCHEMBL28261580 | 0.98 | TAAR1 (0.59) | TAAR1HDAC1HDAC8TRPV1HTR2A | |
| SCHEMBL2094737 | 0.98 | TAAR1 (0.59) | TAAR1HDAC1HDAC8TRPV1HTR2A | |
| SCHEMBL28143319 | 0.98 | TAAR1 (0.59) | TAAR1HDAC1HDAC8TRPV1HTR2A | |
| SCHEMBL256694 | 0.95 | TAAR1 (0.62) | TAAR1HDAC1HDAC8TRPV1HTR2A | |
| SCHEMBL9351319 | 0.94 | HDAC1 (0.57) | TAAR1HDAC1HDAC8TRPV1HTR2A | |
| SCHEMBL30876859 | 0.87 | TAAR1 (0.67) | TAAR1HDAC1HDAC8HTR2AHTR2B | |
| SCHEMBL429769 | 0.87 | TAAR1 (0.67) | TAAR1HDAC1HDAC8HTR2AHTR2B | |
| Hydrochloric Acid SCHEMBL7988615 | 0.85 | TAAR1 (0.65) | TAAR1HDAC1HDAC8HTR2AHTR2B | |
| SCHEMBL27956999 | 0.84 | TAAR1 (0.48) | TAAR1HDAC1HDAC8TRPV1HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11584852-B2 | Compound and colored resin composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-02-21 | — | — | US | disclosed |
| EP-3583100-B1 | COMPOUNDS CONTAINING SI ATOMS FOR OPTICALLY ACTIVE DEVICES | MERCK PATENT GMBH (DE) | 2021-05-05 | — | — | EP | disclosed |
| US-20210002487-A1 | COMPOUND AND COLORED RESIN COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-01-07 | — | — | US | disclosed |
| WO-2019163732-A1 | COMPOUND AND COLORING RESIN COMPOSITION | 住友化学株式会社 | 2019-08-29 | — | — | WO | disclosed |
| US-9840481-B2 | Allosteric modulators of nicotinic acetylcholine receptors | MERCK SHARP & DOHME CORP. (US) | 2017-12-12 | — | — | US | disclosed |
| WO-2017165170-A1 | ELECTRON WITHDRAWING GROUP SUBSTITUTED AND MACROCYCLIC PGJ3 ANALOGS AND METHODS OF TREATMENT THEREOF | WILLIAM MARSH RICE UNIVERSITY (US) | 2017-09-28 | — | — | WO | disclosed |
| EP-1847533-A1 | SIX-MEMBERED HETEROCYCLIC COMPOUND AND THE USE THEREOF | Asahi Kasei Pharma Corporation (JP) | 2007-10-24 | — | — | EP | disclosed |
| US-RE37087-E1 | 1-(4-ETHOXYPHENYL)-4-(4-FLUORO-3-PHENOXYPHENYL)-1 -TRIFLUOROMETHYLBUTANE OR 1-(4-ETHOXY-3-FLUOROPHENYL)-4-(3-PHENOXYPHENYL)-1-TRIFLUOROMETHYLBUTANE, FOR EXAMPLE; COMBATS INSECTS AND MITES | SCHERING AKTIENGESELLSCHAFT (DE) | 2001-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11584852-B2 | Compound and colored resin composition | H1-0, HRH3, HRH4 | TAAR1 1486/4885HDAC1 1401/4885HDAC8 3164/4885 |
| US-20210002487-A1 | COMPOUND AND COLORED RESIN COMPOSITION | H1-0, HRH3, HRH4 | TAAR1 1486/4885HDAC1 1401/4885HDAC8 3164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.